John L. LaMattina
Board Member
Ligand Pharmaceuticals Inc (LGND)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John L. LaMattina
John L. LaMattina is recorded as Board Member at Ligand Pharmaceuticals Inc (LGND). Earlier roles on record: Board Member at Immunome Inc. (IMNM) until October 2, 2023. Ligand Pharmaceuticals Inc reported in an 8-K filed June 17, 2024 that John L. LaMattina was appointed director. Immunome Inc. reported in an 8-K filed October 4, 2023 that John L. LaMattina resigned as Immunome's board of directors and any respective committee membership of Immunome's board of directors, effective October 2, 2023.
“each nominee was elected to serve as a director of the Company.”
“(i) each of Michael Rapoport, Richard Baron, John LaMattina, Ph.D., and Michael Lefenfeld resigned from Immunome's board of directors and any respective committee membership of Immunome's board of directors, effective as of the closing of the Merger”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2011-01-01–present
-
2017-01-01–2023-10-02
-
2017-01-01–2023-10-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ligand Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Todd C. Davis CEO, Board Member
- Tavo Espinoza CFO
- Matthew Korenberg COO
- Jason Haas Board Member
- Jason M. Aryeh Board Member
- Jennifer Cochran, Ph.D. Board Member
- John L. LaMattina, Ph.D. Board Member
- John W. Kozarich Board Member
- John W. Kozarich, Ph.D. Board Member
- Martine Zimmermann Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.